P3-321: APP-selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease

2010 ◽  
Vol 6 ◽  
pp. S546-S546 ◽  
Author(s):  
Sally Schroeter ◽  
Elizabeth Brigham ◽  
Ruth Motter ◽  
Chris Nishioka ◽  
Terry Guido ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Mouse Model ◽  
Amyloid Beta ◽  
Gamma Secretase ◽  
Model Of Alzheimer’S Disease ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor ◽  
Brain Parenchymal

P4-026: Extracellular amyloid-beta pathology induces entorhinal neurodegeneration in PS1(M146L)xAPP(751SL) mouse model of Alzheimer's disease

2009 ◽  
Vol 5 (4S_Part_14) ◽  
pp. P439-P439
Author(s):  
Ines Moreno-Gonzalez ◽  
David Baglietto-Vargas ◽  
Raquel Sanchez-Varo ◽  
Sebastian Jimenez ◽  
Elisabeth Sanchez-Mejias ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Mouse Model ◽  
Amyloid Beta ◽  
Model Of Alzheimer’S Disease

P2-302: GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease

2008 ◽  
Vol 4 ◽  
pp. T461-T461 ◽  
Author(s):  
Steven Jacobsen ◽  
Thomas Comery ◽  
Suzan Aschmies ◽  
Hua Zhou ◽  
Mei Jin ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

scholarly journals Inhibition of the NFAT Pathway Alleviates Amyloid Beta Neurotoxicity in a Mouse Model of Alzheimer's Disease

2012 ◽  
Vol 32 (9) ◽  
pp. 3176-3192 ◽  
Author(s):  
E. Hudry ◽  
H.-Y. Wu ◽  
M. Arbel-Ornath ◽  
T. Hashimoto ◽  
R. Matsouaka ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Mouse Model ◽  
Amyloid Beta ◽  
Model Of Alzheimer’S Disease
Sign in / Sign up

Export Citation Format

Share Document